MOR:ADS (Sponsored)/MorphoSys AG - Stock Price Quote and Dividend Data
MOR STOCK PRICE LATEST CLOSE
$18.96
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
ADS (Sponsored)/MorphoSys AG Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ADS (Sponsored)/MorphoSys AG Stock Price Information
52-Week Low/High Stock Price$4.18 - $19.50
Percent Held by Institutions18.20%
Revenue$259,474,212
Net Income$-371,812,236
Cash Flow$-302,207,262
EPS-8.37%
Market Cap$0
PE Ratio to Industry87%
Debt-Equity Ratio1,000,000.00%
Debt-Equity to Industry1.72%
Total Return Last 12 Months150.79%
Total Return Last 3 Years35.72%
Total Return Last 5 Years-35.86%
Latest Trade DateAug. 02, 2024
ADS (Sponsored)/MorphoSys AG Annual Stock Dividends
No Data available for Payment History.
ADS (Sponsored)/MorphoSys AG Dividend Payment History
| No dividends retrieved for MOR |
ADS (Sponsored)/MorphoSys AG Other Dividend Details
MorphoSys is engaged in the development commercialization of antibodies for therapeutic applications. Co. develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. Co.'s operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. Co. develops new treatments for patients suffering from serious diseases.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 06, 2024MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 02-06-2024 increased stock price > 10% from $11.07 to $17.27
Jan. 27, 2024MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 01-27-2024 increased stock price > 10% from $9.87 to $11.52
Jan. 20, 2024MOR STOCK PRICE DECREASE: ADS (Sponsored)/MorphoSys AG on 01-20-2024 decreased stock price > 10% from $10.24 to $9.17
Jan. 17, 2024MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 01-17-2024 increased stock price > 10% from $8.60 to $10.77
Dec. 12, 2023MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 12-12-2023 increased stock price > 10% from $7.05 to $8.83
Dec. 01, 2023MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 12-01-2023 increased stock price > 10% from $5.95 to $6.84
Nov. 28, 2023MOR STOCK PRICE INCREASE: ADS (Sponsored)/MorphoSys AG on 11-28-2023 increased stock price > 10% from $4.67 to $5.15
Nov. 22, 2023MOR STOCK PRICE DECREASE: ADS (Sponsored)/MorphoSys AG on 11-22-2023 decreased stock price > 10% from $5.86 to $4.55
Nov. 17, 2023MOR STOCK PRICE DECREASE: ADS (Sponsored)/MorphoSys AG on 11-17-2023 decreased stock price > 10% from $6.95 to $6.20
Jul. 28, 2023MOR STOCK PRICE DECREASE: ADS (Sponsored)/MorphoSys AG on 07-28-2023 decreased stock price > 10% from $8.01 to $7.19
Apr. 10, 2025AIMI STOCK PRICE DECREASE: AIM ImmunoTech Inc on 04-10-2025 decreased stock price > 10% from $0.04 to $0.03
Apr. 10, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-10-2025 decreased stock price > 10% from $0.27 to $0.20
Apr. 10, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.05
Apr. 10, 2025SLRX STOCK PRICE DECREASE: Com Par $0.0001/Salarius Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.81 to $0.60
Apr. 10, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-10-2025 decreased stock price > 10% from $1.27 to $1.03
Apr. 10, 2025BGLC STOCK PRICE DECREASE: BioNexus Gene Lab Corp on 04-10-2025 decreased stock price > 10% from $2.63 to $2.17
Apr. 10, 2025BFRGW STOCK PRICE DECREASE: Wt Exp/BullFrog AI Holdings Inc on 04-10-2025 decreased stock price > 10% from $0.60 to $0.50
Apr. 10, 2025BEIGF STOCK PRICE DECREASE: BeiGene Ltd on 04-10-2025 decreased stock price > 10% from $19.01 to $15.95
Apr. 10, 2025BIAFW STOCK PRICE DECREASE: Wt Exp/Bioaffinity Technologies Inc on 04-10-2025 decreased stock price > 10% from $0.22 to $0.14
Apr. 10, 2025LEXTF STOCK PRICE DECREASE: Lexston Mining Corp on 04-10-2025 decreased stock price > 10% from $0.22 to $0.17
